NovaBay Pharmaceuticals I... (NBY)

AI Score

Unlock

0.53

-0.03 (-5.74%)

At close: Apr 04, 2025, 11:03 AM

NovaBay Pharmaceuticals Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003
Revenue	9.75M	14.73M	14.4M	8.42M	9.93M	6.6M	12.51M	18.23M	11.9M	4.38M	1.05M	3.48M	6.95M	11.02M	9.75M	15.68M	6.72M	5.91M	1.53M	n/a	n/a	n/a
Cost of Revenue	3.27M	6.83M	6.62M	2.78M	3.97M	1.74M	1.5M	2.78M	2.46M	1.26M	486K	162K	8K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	6.48M	7.89M	7.78M	5.64M	5.96M	4.86M	11.01M	15.45M	9.43M	3.12M	568K	3.31M	6.94M	11.02M	9.75M	15.68M	6.72M	5.91M	1.53M	n/a	n/a	n/a
Operating Income	-7.21M	-5M	-7.68M	-8.86M	-6.43M	-9.4M	-7.87M	-7.31M	-10.98M	-21.01M	-16.88M	-15.49M	-8.31M	-4.32M	-4.52M	2.74M	-8.51M	-5.88M	-5.53M	-3.57M	-2.8M	-953K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-8.61M	-9.64M	-10.61M	-5.82M	-11.03M	-9.65M	-6.54M	-7.4M	-13.15M	-18.97M	-15.19M	-16.04M	-7.03M	-5.08M	-4.26M	2.7M	-8.11M	-5.39M	-5.29M	-3.46M	n/a	-977K
Net Income	-8.61M	-9.64M	-16.27M	-6.56M	-11.04M	-10.49M	-6.54M	-7.4M	-13.15M	-18.97M	-15.19M	-16.04M	-7.03M	-5.08M	-4.31M	2.7M	-8.11M	-5.4M	-5.29M	-3.46M	-2.8M	-977K
Selling & General & Admin	11.41M	12.83M	15.29M	14.46M	12.11M	14.08M	18.62M	22.35M	19.04M	18.09M	7.93M	6.34M	5.98M	5.43M	5.65M	5.61M	5.64M	4.37M	2.97M	1.62M	n/a	n/a
Research & Development	42K	68K	174K	44K	285K	184K	259K	410K	1.37M	6.04M	9.51M	12.46M	9.28M	9.91M	8.62M	7.34M	9.6M	7.42M	4.09M	1.95M	n/a	270K
Other Expenses	n/a	n/a	-276K	-1.58M	605K	-1.43M	19K	12K	-68K	-96K	22K	1K	-155K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.8M	n/a
Operating Expenses	11.46M	12.9M	15.46M	14.51M	12.39M	14.26M	18.88M	22.76M	20.41M	24.13M	17.45M	18.8M	15.26M	15.34M	14.27M	12.94M	15.23M	11.79M	7.06M	3.57M	-2.8M	953K
Interest Expense	n/a	n/a	n/a	n/a	n/a	1.05M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	4.03M	6.5M	7.8M	7.22M	6.17M	8.77M	12.79M	13.71M	11.81M	10.52M	1.75M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	14.72M	19.73M	22.08M	17.28M	16.36M	16M	20.38M	25.54M	22.88M	25.39M	17.93M	18.96M	15.26M	15.34M	14.27M	12.94M	15.23M	11.79M	7.06M	3.57M	-2.8M	953K
Income Tax Expense	n/a	n/a	-3.81M	-4.62M	5K	6K	4K	3K	2K	12K	2K	2K	2K	2K	50K	7K	2K	12K	-240K	-106K	2.8M	n/a
Shares Outstanding (Basic)	3.4M	120.43K	30K	31.64K	28.63K	16.27K	11.6K	12.51K	n/a	n/a	n/a	n/a	33.46K	29.45K	26.66K	25.6K	24.36K	10.26K	6.53K	5.54K	5K	4.62K
Shares Outstanding (Diluted)	3.4M	120.43K	46K	35.63K	28.63K	17.67K	13.93K	12.51K	n/a	n/a	n/a	n/a	33.66K	29.45K	26.66K	26.42K	24.36K	10.26K	6.53K	5.54K	5K	4.62K
EPS (Basic)	-2.53	-138.65	-353.59	-184.09	-385.53	-593.63	-473.83	-591.81	n/a	n/a	n/a	n/a	-208.8	-172.64	-161.6	105.00	-333.14	-526.52	-809.37	-624.53	-560.46	-211.43
EPS (Diluted)	-2.53	-138.65	-353.59	-184.09	-385.53	-593.63	-564.17	-591.81	n/a	n/a	n/a	n/a	-210	-172.64	-161.6	105.00	-333.14	-526.52	-809.37	-624.53	-560.46	-211.43
EBITDA	-7.21M	-4.8M	-7.2M	-8.74M	-6.38M	-9.34M	-7.61M	-7.22M	-10.87M	-20.97M	-16.67M	-15.17M	-7.97M	-3.9M	-4.09M	3.15M	-7.81M	-5.21M	-5.45M	-3.42M	-2.8M	-929K
EBIT	n/a	-5M	-7.68M	-8.86M	-6.43M	-9.4M	-7.87M	-7.31M	-10.98M	-21.14M	-16.9M	-15.49M	-8.31M	-4.32M	-4.52M	2.74M	-8.51M	-5.88M	-5.53M	-3.46M	-2.8M	n/a
Depreciation & Amortization	n/a	203K	483K	119K	51K	65K	266K	95K	114K	164K	232K	314K	341K	425K	427K	373K	304K	183K	74K	48K	n/a	24K